Sylvester Comprehensive Cancer Center


James Grichnik, M.D., Ph.D.

Sylvester Study Provides New Insights on Melanomas


A new Miller School study led by James Grichnik, M.D., Ph.D., professor of dermatology and cutaneous surgery, provides new insights into the genetic mutations that can lead to melanomas. "Mutations driving melanoma growth have diagnostic, prognostic and therapeutic implications," said Grichnik.

Gov. Rick Scott is given a symbolic white lab coat during his visit to Sylvester Comprehensive Cancer Center. Applauding his efforts are, from left, Pascal J. Goldschmidt, M.D., Donna E. Shalala, Stuart Miller, Stephen D. Nimer, M.D., and far right, patient Billy Thies.

Governor Scott Visits Sylvester to Promote 2014 State Cancer Budget


Florida Governor Rick Scott visited the Miller School’s Sylvester Comprehensive Cancer Center on Friday, March 14, to tout the $80 million earmarked for cancer treatment and research in his proposed $1.4 billion 2014 state budget, and to support Sylvester’s efforts to receive official designation from the National Cancer Institute.

Dolphins Cycling Challenge partners, from left, Stuart Miller, Joe Natoli, W. Jarrard Goodwin, M.D., Stephen Nimer, M.D., Richard Berkowitz, Michael Mandich and Tom Garfinkel.

Dolphins Cycling Challenge Donates $3.1 Million to Tackle Cancer


Executives from the Dolphins Cycling Challenge presented Stephen D. Nimer, M.D., Director of the Sylvester Comprehensive Cancer Center, with a check for $3.1 million to tackle cancer. Launched in 2010 as a partnership between Sylvester and the Miami Dolphins, the Dolphins Cycling Challenge is a two-day, tri-county cycling event, from which 100 percent of rider-raised funds are donated to Sylvester.

Enrique A. Mesri, Ph.D.

Sylvester/AIDS Researcher Unifies Theory on Human Viral Oncogenesis


Despite prevalence, public health importance, and the fact that virus-induced cancers are the most preventable through vaccination or anti-viral therapy, this group remains among the least understood of all cancers. A study led by Enrique A. Mesri, Ph.D., associate professor of microbiology and immunology, sheds light on this group of cancers and may help develop new targeted therapies.

Mark Soloway, M.D., third from left, received an award for his lifetime service to urologic oncology. Congratulating him were, from left, conference organizers Balakrishna Lokeshwar, Ph.D., and  Vinata Lokeshwar, Ph.D., conference sponsor Edwin Cevallos, M.D., Dean Pascal J. Goldschmidt, M.D., and Sylvester Director Stephen D. Nimer, M.D.

Inaugural Cancer Symposium Shares Research Findings


Three of the nation’s top cancer researchers — each targeting a different form of the disease — were the keynote speakers at the University of Miami Cancer Symposium “Cancer Prevention and Treatment,” held January 24 at the Lois Pope LIFE Center Auditorium. The symposium was organized under the auspices of the Sylvester Comprehensive Cancer Center and the Department of Urology.

Tan A. Ince, M.D., Ph.D.

Researchers Discover New Hormone Receptors to Target When Treating Breast Cancer


In a new study directed by Tan A. Ince, M.D., Ph.D., associate professor of pathology at the Miller School of Medicine and member of the Sylvester Comprehensive Cancer Center, researchers have developed a new breast cancer classification system that shifts the focus away from genetic mutations, a common approach of mainstream cancer research, but one that has been less effective than first imagined.

Karina Galoian, Ph.D., and H. Thomas Temple, M.D.

Study Identifies Novel Highlights for Sarcoma Research


Researchers at the Miller School, led by Karina Galoian, Ph.D., research associate professor of orthopaedics, have uncovered pathways linked to the genesis of chondrosarcoma, cancer of the cells that produce cartilage. The study, “Lost miRNA surveillance of Notch, IGFR pathway -- road to sarcomagenesis,” was published in the January issue of Tumor Biology.